Literature DB >> 32496421

Fecal Microbiota Transplantation and Hydrocortisone Ameliorate Intestinal Barrier Dysfunction and Improve Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis.

Stelios F Assimakopoulos1, Iliana Papadopoulou2, Dimitra Bantouna3, Anne-Lise de Lastic4, Maria Rodi4, Athanasia Mouzaki4, Charalambos A Gogos1, Vasiliki Zolota3, Ioannis Maroulis2.   

Abstract

INTRODUCTION: Sepsis is a life-threatening syndrome which can progress to multiple organ dysfunction with high mortality. Intestinal barrier failure exerts a central role in the pathophysiological sequence of events that lead from sepsis to multiple organ dysfunction. The present study investigated the role of hydrocortisone (HC) administration and fecal microbiota transplantation (FMT) in several parameters of the gut barrier integrity, immune activation, and survival, in a model of polymicrobial sepsis in rats.
METHODS: Forty adults male Wistar rats were randomly divided into four groups: sham (group I), cecal ligation and puncture (CLP) (group II), CLP + HC (2.8 mg/kg, intraperitoneally single dose at 6 h) (group III), and CLP + FMT at 6 h (group IV). At 24 h post-CLP, ileal tissues were harvested for histological and immunohistochemical analyses while endotoxin, IL-6, and IL-10 levels in systemic circulation were determined. In a second experiment the same groups were observed for 7 days for mortality, with daily administration of hydrocortisone (group III) and FMT (group IV) in surviving rats.
RESULTS: HC administration and FMT significantly reduced mortality of septic rats by 50%. These interventions totally reversed intestinal mucosal atrophy by increasing villous density and mucosal thickness (μm, mean ± SD: Group I: 620 ± 35, Group II: 411 ± 52, Group III: 622 ± 19, Group IV: 617 ± 44). HC and FMT reduced the apoptotic body count in intestinal crypts whereas these increased the mitotic/apoptotic index. Activated caspase-3 expression in intestinal crypts was significantly reduced by HC or FMT (activated caspase-3 (+) enterocytes/10 crypts, mean ± SD: Group I: 1.6 ± 0.5, Group II: 5.8 ± 2.4, Group III: 3.6 ± 0.9, Group IV: 2.3 ± 0.6). Both treatments increased Paneth cell count and decreased intraepithelial CD3(+) T lymphocytes and inflammatory infiltration of lamina propria to control levels. In the sham group almost the total of intestinal epithelial cells expressed occludin (92 ± 8%) and claudin-1 (98 ± 4%) and CLP reduced this expression to 34 ± 12% for occludin and 35 ± 7% for claudin-1. Administration of HC significantly increased occludin (51 ± 17%) and claudin-1 (77 ± 9%) expression. FMT exerted also a significant restoring effect in tight junction by increasing occludin (56 ± 15%) and claudin-1 (84 ± 7%) expression. The beneficial effects of these treatments on gut barrier function led to significant reduction of systemic endotoxemia (EU/mL, mean ± SD: Group I: 0.93 ± 0.36, Group II: 2.14 ± 1.74, Group III: 1.48 ± 0.53, Group IV: 1.61 ± 0.58), while FMT additionally decreased IL-6 and IL-10 levels.
CONCLUSION: Fecal microbiota transplantation and stress dose hydrocortisone administration in septic rats induce a multifactorial improvement of the gut mechanical and immunological barriers, preventing endotoxemia and leading to improved survival.
Copyright © 2020 by the Shock Society.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32496421     DOI: 10.1097/SHK.0000000000001566

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

Review 1.  SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction.

Authors:  Stelios F Assimakopoulos; Gerasimos Eleftheriotis; Maria Lagadinou; Vassilios Karamouzos; Periklis Dousdampanis; Georgios Siakallis; Markos Marangos
Journal:  Microorganisms       Date:  2022-05-19

Review 2.  The role of bacterial translocation in sepsis: a new target for therapy.

Authors:  Assaf Potruch; Asaf Schwartz; Yaron Ilan
Journal:  Therap Adv Gastroenterol       Date:  2022-05-09       Impact factor: 4.802

Review 3.  Faecal Microbiota Transplantation and Chronic Kidney Disease.

Authors:  Ji Bian; Ann Liebert; Brian Bicknell; Xin-Ming Chen; Chunling Huang; Carol A Pollock
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

Review 4.  Contribution of gut microbiota toward renal function in sepsis.

Authors:  Yaya Xu; Xiangmei Kong; Yueniu Zhu; Jiayue Xu; Haoyun Mao; Jiru Li; Jianhua Zhang; Xiaodong Zhu
Journal:  Front Microbiol       Date:  2022-09-06       Impact factor: 6.064

5.  Secondary Dysfunction of the Intestinal Barrier in the Pathogenesis of Complications of Acute Poisoning.

Authors:  Ju Ju Ivnitsky; T V Schäfer; V L Rejniuk; O A Vakunenkova
Journal:  J Evol Biochem Physiol       Date:  2022-08-28       Impact factor: 1.621

6.  Gut Microbiota Was Involved in the Process of Liver Injury During Intra-Abdominal Hypertension.

Authors:  Zeyu Zhao; Zhengchang Guo; Zhengliang Yin; Yue Qiu; Bo Zhou
Journal:  Front Physiol       Date:  2021-12-10       Impact factor: 4.566

Review 7.  Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls.

Authors:  Cassandra E Gheorghe; Nathaniel L Ritz; Jason A Martin; Hannah R Wardill; John F Cryan; Gerard Clarke
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.